Three new drugs for hereditary angioedema.
D054179:Angioedemas, Hereditary / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003174:Complement C1 Inactivator Proteins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D050718:Complement C1 Inhibitor Protein / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D010455:Peptides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D003174:Complement C1 Inactivator Proteins; D050718:Complement C1 Inhibitor Protein; D010455:Peptides; C469952:SERPING1 protein, human; C511194:ecallantide